HESI RN CASE STUDY EVOLVE PRACTICE TEST BSN

HESI RN CASE STUDY EVOLVE PRACTICE TEST BSNAntacids • neutralize gastric acids and keep pH of 3.5 or above Lactulose • 2 or 3 soft stools per day is the indicated result Digoxin • For CHF • ***ASSESS serum K POTASSIUM level before administering** • VOMITING, ANOREXIA, ABDOMINAL PAIN are early indications of digitalis toxicity • Combo with Lipitor increases digitalis toxicity (VOMITING req’s immediate intervention) • Client @ GREATEST RISK FOR HYPOKALEMIA Nitroglycerin • Relieves chest pain Captopril • ACE inhibitor for CHF to reduce HF (decreases BP and prevents vasoconstriction) • Report dizziness Propylthiouracil (PTU) • Hyperthyroidism tx • Inhibits synthesis of T3 and T4 by thyroid gland Carbidopa-levodopa (Sinemet) • Lessens tremors Warfarin • Measure prothrombin time (PT/INR) regularly at discharge Valsartan (Diovan) • Reduces BP aka tx hypertension • Angiotensin receptor blocker Meperidine (Demerol) • If adverse s&s, decrease IV infusion rate Alendronate (Fosamax) • Osteoporosis • -Take med, go for 30 min walk, then eat breakfast • (30 min before eating) remain upright for 30 minutes after taking d/t reflux Metoprolol (Lopressor) • Obtain BP Procainamide (Pronestyl) • 4 doses = q6h Adenosine (Adenocard) • Antiarrhythmic drug • Cardiac monitoring Dopamine and IV saline 50 ml/hr • 20 ml/hr urine output = notify HCP ***Atorvastatin (Lipitor) • Muscle pain and weakness make appointment with HCP *****